Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers

Cited by papers we hold 11

• NRF2, a Superstar of Ferroptosis · 2023
  No notice
• An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases · 2021
  No notice
• Regulation of Nrf2/ARE Pathway by Dietary Flavonoids: A Friend or Foe for Cancer Management? · 2020
  No notice
• NRF2, a Transcription Factor for Stress Response and Beyond · 2020
  No notice
• The KEAP1–NRF2 System as a Molecular Target of Cancer Treatment · 2020
  No notice
• Potential Applications of NRF2 Inhibitors in Cancer Therapy · 2019
  No notice
• Nrf2 in cancers: A double‐edged sword · 2019
  No notice
• Transcriptional Regulation by Nrf2 · 2018
  No notice
• p62/ SQSTM 1: ‘Jack of all trades’ in health and cancer · 2018
  No notice
• A catalogue of somatic NRF2 gain-of-function mutations in cancer · 2018
  No notice
• Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer · 2017
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.